Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.
Hideshima T, Podar K, Chauhan D, Ishitsuka K, Mitsiades C, Tai YT, Hamasaki M, Raje N, Hideshima H, Schreiner G, Nguyen AN, Navas T, Munshi NC, Richardson PG, Higgins LS, Anderson KC.
Hideshima T, et al. Among authors: raje n.
Oncogene. 2024 Sep;43(40):3018. doi: 10.1038/s41388-024-03147-5.
Oncogene. 2024.
PMID: 39209967
No abstract available.